Your browser doesn't support javascript.
loading
Pharmacokinetics and tolerability of paritaprevir, a direct acting antiviral agent for hepatitis C virus treatment, with and without ritonavir in healthy volunteers.
Menon, R M; Klein, C E; Podsadecki, T J; Chiu, Y-L; Dutta, S; Awni, W M.
Afiliação
  • Menon RM; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Klein CE; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Podsadecki TJ; Infectious Diseases, R48U, AP-30, AbbVie, 1 North Waukegan Road, North Chicago, Illinois, 60064.
  • Chiu YL; Department of Biometrics, AbbVie, 1 North Waukegan Road, AP31-2, North Chicago, Illinois, 60064.
  • Dutta S; Clinical Pharmacokinetics and Pharmacodynamics, AbbVie, 1 North Waukegan Road, AP31-3, North Chicago, Illinois, 60064.
  • Awni WM; Clinical Pharmacology and Pharmacometrics, AbbVie, 1 North Waukegan Road, R4PD AP31-3, North Chicago, IL, 60064, USA.
Br J Clin Pharmacol ; 81(5): 929-40, 2016 May.
Article em En | MEDLINE | ID: mdl-26710243

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ritonavir / Hepatite C Crônica / Compostos Macrocíclicos / Inibidores do Citocromo P-450 CYP3A Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ritonavir / Hepatite C Crônica / Compostos Macrocíclicos / Inibidores do Citocromo P-450 CYP3A Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2016 Tipo de documento: Article